Ruxolitinib - a Steroid Sparing Agent in Chronic Graft-versus-Host Disease

Inhibition of the Janus-associated kinases (JAK) with ruxolitinib (RUX) reduces graft-versus-host disease (GVHD) in preclinical and clinical models. Nineteen allograft recipients with moderate/severe steroid-dependent chronic GVHD received RUX as ≥ 2nd line salvage. RUX was well tolerated, and led t...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Bone Marrow Transplant
Autors principals: Khoury, Hanna Jean, Langston, Amelia A., Kota, Vamsi K., Wilkinson, Jennifer A., Pusic, Iskra, Jillella, Anand, Bauer, Stephanie, Kim, Audrey S, Roberts, Danielle, Al-Kadhimi, Zaid, Bodo, Imre, Winton, Elliott, Arellano, Martha, DiPersio, John F.
Format: Artigo
Idioma:Inglês
Publicat: 2018
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6041160/
https://ncbi.nlm.nih.gov/pubmed/29367708
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41409-017-0081-5
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars